Cytokines in immunopathogenesis of multiple sclerosis

被引:0
|
作者
Demina, TL [1 ]
Gusev, EI [1 ]
Boiko, AN [1 ]
Pinegin, BV [1 ]
机构
[1] RUSSIAN ACAD MED SCI, INST IMMUNOL, MOSCOW, RUSSIA
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:68 / 73
页数:6
相关论文
共 50 条
  • [41] The role of adenosine and adenosine receptors in the immunopathogenesis of multiple sclerosis
    Safarzadeh, Elham
    Jadidi-Niaragh, Farhad
    Motallebnezhad, Morteza
    Yousefi, Mehdi
    INFLAMMATION RESEARCH, 2016, 65 (07) : 511 - 520
  • [42] Immunopathogenesis, Diagnosis, and Treatment of Multiple Sclerosis: A Clinical Update
    Perez, Carlos A.
    Cuascut, Fernando X.
    Hutton, George J.
    NEUROLOGIC CLINICS, 2023, 41 (01) : 87 - 106
  • [43] The role of adenosine and adenosine receptors in the immunopathogenesis of multiple sclerosis
    Elham Safarzadeh
    Farhad Jadidi-Niaragh
    Morteza Motallebnezhad
    Mehdi Yousefi
    Inflammation Research, 2016, 65 : 511 - 520
  • [44] HLA ASSOCIATIONS IN MULTIPLE-SCLEROSIS - IMPLICATIONS FOR IMMUNOPATHOGENESIS
    VARTDAL, F
    RESEARCH IN IMMUNOLOGY, 1989, 140 (02): : 192 - 196
  • [45] Cytokines and Chemokines in Multiple Sclerosis
    Mazzi, V.
    CLINICA TERAPEUTICA, 2015, 166 (01): : E62 - E66
  • [46] Pivotal cytokines and their transcription factors are the targets of guluronic acid (G2013) for inhibiting the immunopathogenesis process of multiple sclerosis
    Hossein-khannazer, Nikoo
    Shabani, Samira
    Farokhfar, Mohadeseh
    Azizi, Gholamreza
    Asarzadegan, Farhad
    Lima, Behnam Safarpour
    Mirshafeiey, Abbas
    DRUG DEVELOPMENT RESEARCH, 2020, 81 (04) : 511 - 516
  • [47] A role for natural killer (NK) cells in the immunopathogenesis of multiple sclerosis
    Kastrukoff, LF
    Morgan, N
    Zecchini, D
    Satoh, J
    Paty, D
    NEUROLOGY, 1997, 48 (03) : 1112 - 1112
  • [48] Role of Proangiogenic Factors in Immunopathogenesis of Multiple Sclerosis: A Systematic Review
    Hamid, Kabir Magaji
    Mirshafiey, Abbas
    IRANIAN JOURNAL OF ALLERGY ASTHMA AND IMMUNOLOGY, 2016, 15 (01) : 1 - 12
  • [49] Current model of immunopathogenesis of multiple sclerosis - new therapeutic options
    Bartosik-Psujek, Halina
    AKTUALNOSCI NEUROLOGICZNE, 2014, 14 (02): : 117 - 123
  • [50] Natural killer (NK) cells in the immunopathogenesis of multiple sclerosis (MS)
    Kastrukoff, LF
    Lau, AS
    Zecchini, D
    FASEB JOURNAL, 2000, 14 (06): : A1023 - A1023